S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.15 CNY -0.1%
Market Cap: 34.7B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Shenzhen Salubris Pharmaceuticals Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shenzhen Salubris Pharmaceuticals Co Ltd
Accounts Payable Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
S
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Accounts Payable
ÂĄ145.7m
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
2%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accounts Payable
ÂĄ163.8m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accounts Payable
ÂĄ470.9m
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
20%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accounts Payable
ÂĄ1.4B
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
17%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accounts Payable
ÂĄ4.5B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accounts Payable
ÂĄ307.9m
CAGR 3-Years
65%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Accounts Payable?
Accounts Payable
145.7m CNY

Based on the financial report for Jun 30, 2024, Shenzhen Salubris Pharmaceuticals Co Ltd's Accounts Payable amounts to 145.7m CNY.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
2%

Over the last year, the Accounts Payable growth was 6%. The average annual Accounts Payable growth rates for Shenzhen Salubris Pharmaceuticals Co Ltd have been 3% over the past three years , 5% over the past five years , and 2% over the past ten years .

Back to Top